(Q43823404)

27 November 2017

The immunosuppressant drug FK506 is a potent trophic agent for human fetal neurons (English)

1 reference

27 November 2017

1 reference

Avramut M

1

1 reference

PubMed ID

11744119

27 November 2017

Zeevi A

series ordinal

2

1 reference

PubMed ID

11744119

27 November 2017

Achim CL

series ordinal

3

1 reference

27 November 2017

1 December 2001

1 reference

27 November 2017

7

1 reference

Developmental Brain Research

inferred from page(s)

published in

1 reference

27 November 2017

132

1 reference

27 November 2017

151-157

1 reference

27 November 2017

2

1 reference

The effects of FK506 on dorsal column axons following spinal cord injury in adult rats: neuroprotection and local regeneration.

27 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2801%2900307-8

7 January 2021

FK506 and cyclosporin A enhance the survival of cultured and grafted rat embryonic dopamine neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2801%2900307-8

7 January 2021

A novel immunophilin ligand: distinct branching effects on dopaminergic neurons in culture and neurotrophic actions after oral administration in an animal model of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2801%2900307-8

7 January 2021

Immunophilin ligands and GDNF enhance neurite branching or elongation from developing dopamine neurons in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2801%2900307-8

7 January 2021

The immunophilins, FK506 binding protein and cyclophilin, are discretely localized in the brain: relationship to calcineurin

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2801%2900307-8

7 January 2021

Two cytoplasmic candidates for immunophilin action are revealed by affinity for a new cyclophilin: one in the presence and one in the absence of CsA

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2801%2900307-8

7 January 2021

The immunosuppressant FK506 increases the rate of axonal regeneration in rat sciatic nerve

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2801%2900307-8

7 January 2021

A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2801%2900307-8

7 January 2021

Response of cell cycle proteins to neurotrophic factor and chemokine stimulation in human neuroglia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2801%2900307-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0165-3806%2801%2900307-8

1 reference

7 January 2021

Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2801%2900307-8

7 January 2021

The effects of growth factors on the survival and differentiation of cultured dentate gyrus neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2801%2900307-8

7 January 2021

Immunosuppressant FK506 promotes neurite outgrowth in cultures of PC12 cells and sensory ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2801%2900307-8

7 January 2021

Tacrolimus (FK506) increases neuronal expression of GAP-43 and improves functional recovery after spinal cord injury in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2801%2900307-8

7 January 2021

An alternative method for obtaining high-viability cell suspensions from neonatal mouse brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2801%2900307-8

7 January 2021

Spectrum of human immunodeficiency virus-associated neocortical damage

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2801%2900307-8

7 January 2021

Amyloid precursor proteins protect neurons of transgenic mice against acute and chronic excitotoxic injuries in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2801%2900307-8

7 January 2021

The mechanism of action of cyclosporin A and FK506

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2801%2900307-8

7 January 2021

Immunophilins in the nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2801%2900307-8

7 January 2021

High brain densities of the immunophilin FKBP colocalized with calcineurin

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2801%2900307-8

7 January 2021

Neurotrophic actions of nonimmunosuppressive analogues of immunosuppressive drugs FK506, rapamycin and cyclosporin A

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2801%2900307-8

7 January 2021

Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2801%2900307-8

7 January 2021

FK 506 and autoimmune disease: perspective and prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2801%2900307-8

7 January 2021

Mode of action of tacrolimus (FK506): molecular and cellular mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2801%2900307-8

7 January 2021

Neuron-enriched second trimester human cultures: growth factor response and in vivo graft survival.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2801%2900307-8

7 January 2021

The immunophilin ligand FK506, but not GPI-1046, protects against neuronal death and inhibits c-Jun expression in the substantia nigra pars compacta following transection of the rat medial forebrain bundle

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2801%2900307-8

7 January 2021

10.1016/S0165-3806(01)00307-8

Identifiers

DOI

1 reference

27 November 2017

1 reference

PubMed ID

11744119